TRADING QUOTES 4:24 PM October 4, 2022
IPO Terms Details Business Combination Related Articles SEC Filings
SPAC Name : 5:01 Acquisition Corporation
Total Public Proceeds at IPO($mm): 82.6
%Held in Trust: 100.0
$Held in Trust per Unit: $ 10.00
Mgmt's Sector Expertise/Focus: BioTech
IPO Date: 2020-10-14
Months to Complete: 24
Deadline Date: 2022-10-16
Unit Structure (---)
Share (FVAM): 1 Class A Common Stock
Warrant (---) None Warrant
Right()
Public Warrant Terms:
Exercise Price: N/A
Redemption Price: N/A
Redemption: Cash, Cashless or for Shares N/A
Underwriters:
Book-runner(s): BofA Securities, Inc.
Co-Manager(s):
Fees (Upfront/Deferred): 2.0%/3.5%
Lawyers:
Issuer's Counsel: Cooley LLP
Underwriter's Counsel: Shearman & Sterling LLP
Additional Terms: IOI: $25M of shares at $10.00 by Sponsor (5AM Venture Mgmt)
SPAC Name: 5:01 Acquisition Corporation
CURRENT FUNDS in TRUST: $82,665,534*
EST. PRO RATA AMOUNT IN TRUST: $10.01*
IMPLIED ENTERPRISE VALUE: 0
RECORD DATE: TBD
SHAREHOLDER VOTE DATE: TBD
SPAC NameSource: SEC.gov filings and SPAC Insider estimates
TRADING QUOTES       Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.